Epilepsy affects around 3.5% of Australians and is defined as ‘refractory’ if patients fail to control seizures with two or more anti-epileptic drugs. Refractory epilepsy is a chronic condition greatly diminishing patients’ quality of life, leading to poor psychosocial adjustment and co-morbidity. For refractory patients, surgical intervention can be effective for long-term seizure control. However, assessment can be extensive, and delays can negatively affect clinical outcomes. This study examined gaps in treatment for refractory epilepsy patients and their impact on resource-management, burden of disease and surgical underutilisation1 in order to: clarify patient pathways and service delivery and reveal experiential knowledge of routine clinical consultation and surgery to enhance patient safety and create smoother service transitions.
|Number of pages||1|
|Publication status||Published - 2018|
|Event||35th International Conference in Healthcare Quality and Safety (ISQUA) - Kuala Lumpur, Malaysia|
Duration: 23 Sept 2018 → 26 Sept 2018
|Conference||35th International Conference in Healthcare Quality and Safety (ISQUA)|
|Period||23/09/18 → 26/09/18|